Return to previous page

HMM304 - Therapeutic Development

Unit details

Year2015 unit information
Enrolment modes:Trimester 2: Burwood (Melbourne), Waurn Ponds (Geelong)
Credit point(s):1
EFTSL value:0.125
Unit chair:

Sarah Shigdar





Incompatible with:


Contact hours:

3 x 1 hour classes per week, and Cloud (online) exercises, case studies, debates and discussions


This unit describes how therapeutic targets are identified and how new therapies are developed for human use. It will provide an overview of the major therapeutic classes, including synthetic compounds, natural products, vaccines, nutriceuticals and other biological agents, and covers the therapeutic development pipeline, encompassing target identification and validation, therapeutic discovery and development, pre-clinical trials and toxicity testing.


Assessment task 1: Mid-trimester test (45 minutes) 20%

Assessment task 2: Written report (1500 words) 30%

Assessment task 3: Examination (2 hours) 50%

Prescribed texts

Raymond G. Hill & Humphrey P. Rang. Drug Discovery and development second edition 2013.

Unit Fee Information

Student Contribution Rate*Student Contribution Rate**Fee rate - Domestic Students Fee rate - International students

* Rate for all CSP students, except for those who commenced Education and Nursing units pre 2010
** Rate for CSP students who commenced Education and Nursing units pre 2010
Please note: Unit fees listed do not apply to Deakin Prime students.

Return to previous page